Healthcare -
Biotechnology - NASDAQ - US
$ 1.875
-3.85 %
$ 393 M
Market Cap
-1.21
P/E
ALLO - DEPRECIATION & AMORTIZATION
Depreciation & Amortization ALLO - Allogene Therapeutics, Inc.
14.2 M
LAST VALUE
16.54%
2 YEAR CAGR
56.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR